In European law, pharmaceutical companies and wholesalers must ensure an appropriate and continuous supply of the medicines they market. Companies should notify the HPRA of medicines shortages or potential shortages impacting the Irish market
We publish and maintain an up-to-date list of a medicines shortages impacting the Irish market. The information we provide is to help keep patients and healthcare professionals informed of current and resolved shortages.
We recognise that medicine shortages can be challenging for those relying on medicines for their health and well-being. Many medicines supplied in Ireland have more than one strength, form, pack size or brand available from different suppliers. If the medicine you have been taking is not available, your doctor or pharmacist will often be able to supply an alternative strength, form, or product. This will help ensure continuity of treatment.
Further information on medicines shortages for patients and healthcare professionals is provided below. This includes information on preventing, managing, and reporting shortages.
About medicines shortages
Our About medicines shortages page includes information on:
- The definition of a medicine shortage.
- Why shortages can occur.
- How medicines shortages are handled in Ireland including details of the Medicines Shortages Framework
Reporting a medicine shortage
Specific product updates - GLP-1 receptor agonists and Concerta XL
We maintain a list of resolved shortages showing where medicine supply has resumed. This list, which covers a six-month period, is updated regularly by the HPRA with information on resupply provided by companies.
Medicinal Product Shortages Unit
Health Products Regulatory Authority
Kevin O’Malley House
Tel: +353 1 676 4971
Fax: +353 1 676 7836 firstname.lastname@example.org